BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22736106)

  • 21. [Plasma metabonomics analysis of tumor patients of phlegm-stasis syndrome].
    Mamtimin B; Upur H
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Apr; 31(4):492-5. PubMed ID: 21608220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pattern recognition analysis for hepatotoxicity induced by acetaminophen using plasma and urinary 1H NMR-based metabolomics in humans.
    Kim JW; Ryu SH; Kim S; Lee HW; Lim MS; Seong SJ; Kim S; Yoon YR; Kim KB
    Anal Chem; 2013 Dec; 85(23):11326-34. PubMed ID: 24127682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ¹H NMR-based metabolomic study of metabolic profiling for systemic lupus erythematosus.
    Ouyang X; Dai Y; Wen JL; Wang LX
    Lupus; 2011 Nov; 20(13):1411-20. PubMed ID: 21976403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Esophageal cancer metabolite biomarkers detected by LC-MS and NMR methods.
    Zhang J; Bowers J; Liu L; Wei S; Gowda GA; Hammoud Z; Raftery D
    PLoS One; 2012; 7(1):e30181. PubMed ID: 22291914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of blood plasma.
    Rocha CM; Carrola J; Barros AS; Gil AM; Goodfellow BJ; Carreira IM; Bernardo J; Gomes A; Sousa V; Carvalho L; Duarte IF
    J Proteome Res; 2011 Sep; 10(9):4314-24. PubMed ID: 21744875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urine metabonomic profiling of a female adolescent with PIT-1 mutation before and during growth hormone therapy: insights into the metabolic effects of growth hormone.
    Abd Rahman S; Schirra HJ; Lichanska AM; Huynh T; Leong GM
    Growth Horm IGF Res; 2013; 23(1-2):29-36. PubMed ID: 23380306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1H NMR-based metabonomic analysis of serum and urine in a nonhuman primate model of diabetic nephropathy.
    Liu J; Wang D; Chen Y; Sun H; He S; Wang C; Yang G; Shi M; Zhang J; Ren Y; Wang L; Lu Y; Cheng J
    Mol Biosyst; 2013 Nov; 9(11):2645-52. PubMed ID: 24228270
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Huo T; Fang Y; Zhao L; Xiong Z; Zhang Y; Wang Y; Feng C; Yuan M; Wang S; Chen M; Jiang H
    J Ethnopharmacol; 2016 Nov; 192():1-9. PubMed ID: 27377338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma metabonomic analysis with ¹H nuclear magnetic resonance revealing the relationship of different tumors and the disease homology theory of traditional Uyghur medicine.
    Mamtimin B; Upur H; Hao FH; Matsidik A; Rahim R
    Chin J Integr Med; 2011 Feb; 17(2):111-5. PubMed ID: 21390577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary metabolomic signature of esophageal cancer and Barrett's esophagus.
    Davis VW; Schiller DE; Eurich D; Sawyer MB
    World J Surg Oncol; 2012 Dec; 10():271. PubMed ID: 23241138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabonomic profiling of serum and urine by (1)H NMR-based spectroscopy discriminates patients with chronic obstructive pulmonary disease and healthy individuals.
    Wang L; Tang Y; Liu S; Mao S; Ling Y; Liu D; He X; Wang X
    PLoS One; 2013; 8(6):e65675. PubMed ID: 23755267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Histidine Supplementation on Global Serum and Urine
    Du S; Sun S; Liu L; Zhang Q; Guo F; Li C; Feng R; Sun C
    J Proteome Res; 2017 Jun; 16(6):2221-2230. PubMed ID: 28447460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The
    Rådjursöga M; Lindqvist HM; Pedersen A; Karlsson GB; Malmodin D; Brunius C; Ellegård L; Winkvist A
    Nutr J; 2019 Apr; 18(1):25. PubMed ID: 30961592
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Akhtar MT; Samar M; Shami AA; Mumtaz MW; Mukhtar H; Tahir A; Shahzad-Ul-Hussan S; Chaudhary SU; Kaka U
    Molecules; 2021 Jul; 26(15):. PubMed ID: 34361796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in the metabolome of rats after exposure to arginine and N-carbamylglutamate in combination with diquat, a compound that causes oxidative stress, assessed by 1H NMR spectroscopy.
    Liu G; Xiao L; Cao W; Fang T; Jia G; Chen X; Zhao H; Wu C; Wang J
    Food Funct; 2016 Feb; 7(2):964-74. PubMed ID: 26732548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinguishing pancreatic cancer from chronic pancreatitis and healthy individuals by (1)H nuclear magnetic resonance-based metabonomic profiles.
    Zhang L; Jin H; Guo X; Yang Z; Zhao L; Tang S; Mo P; Wu K; Nie Y; Pan Y; Fan D
    Clin Biochem; 2012 Sep; 45(13-14):1064-9. PubMed ID: 22613268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of 1H NMR-based metabonomics in the study of metabolic profiling of human hepatocellular carcinoma and liver cirrhosis.
    Gao H; Lu Q; Liu X; Cong H; Zhao L; Wang H; Lin D
    Cancer Sci; 2009 Apr; 100(4):782-5. PubMed ID: 19469021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urine-NMR metabolomics for screening of advanced colorectal adenoma and early stage colorectal cancer.
    Kim ER; Kwon HN; Nam H; Kim JJ; Park S; Kim YH
    Sci Rep; 2019 Mar; 9(1):4786. PubMed ID: 30886205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic and characteristic metabolites in the serum of streptozotocin-induced diabetic rats at different stages as revealed by a (1)H-NMR based metabonomic approach.
    Diao C; Zhao L; Guan M; Zheng Y; Chen M; Yang Y; Lin L; Chen W; Gao H
    Mol Biosyst; 2014 Mar; 10(3):686-93. PubMed ID: 24448714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabonomic characteristics and biomarker research of human lung cancer tissues by HR1H NMR spectroscopy.
    Chen W; Lu S; Ou J; Wang G; Zu Y; Chen F; Bai C
    Cancer Biomark; 2016 Mar; 16(4):653-64. PubMed ID: 27002768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.